Post-earnings recap
Reported
Mon, May 12, 2025
EPS actual
$0.27
EPS est.
$0.18
EPS surprise
+50.00%
1-day move
+129.43%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
CytomX Therapeutics reported a strong EPS of $0.27, significantly beating expectations, although revenue details were not disclosed. The stock reacted positively, soaring by 129.43%, likely driven by investor enthusiasm over the earnings surprise. The lack of guidance and additional commentary leaves some uncertainty about future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.27 | N/A | +50.00% |
| Revenue | — | N/A | — |
No transcript is on record, and the analysis is based on numerical results only.